Efficacy of Structured Exercise Protocol on Patient-Related Outcome Measures, Blood Pressure, And Waist-Hip Ratio in Post Myocardial Infarction Subjects with Hypertension
DOI:
https://doi.org/10.52783/jns.v14.2028Keywords:
Post myocardial infarction, Hypertension, Patient related outcome measures, Blood Pressure, Waist hip ratioAbstract
Hypertension, commonly known as high blood pressure, is a chronic condition where the force of blood against artery walls remains consistently high. Hypertension is a widespread global health concern, affecting over 1.2 billion people worldwide. Its prevalence is increasing due to factors like aging populations, unhealthy lifestyles, and rising obesity rates. It is a major risk factor for heart disease, stroke, and other serious health complications. The study was conducted to find the efficacy of structured exercise protocol training in post-angioplasty subjects with hypertension. A total of 168 subjects were selected, met the inclusion and exclusion criteria, and were randomly divided into two groups. Group A (n= 84) received conventional physiotherapy with lifestyle modifications and Group B (n= 84) received structured exercise training for 6 months. Subjects were evaluated based on pre and post assessment by patient related outcome measures, blood pressure and waist hip ratio. Both the groups showed significant improvement but Group B showed much substantial improvement as compared to Group A. Group B ( anxiety p < 0.000, depression p < 0.000, sleep disturbance p < 0.000, QOL - physical functioning p < 0.000, emotional p < 0.001, social p < 0.029and social function p < 0.389 ), blood pressure - systolic p < 0.000, diastolic p < 0.485 and waist-hip ratio p < 0.70, indicating the rejection of null hypothesis and acceptance of structured exercise protocol. Given the robust evidence supporting the benefits of cardiac rehabilitation, it should be incorporated into standard post-MI care protocols to improve long-term cardiovascular outcomes.
Downloads
Metrics
References
World Health Organization (WHO) (2023). "Global Report on Hypertension 2023." WHO Press.
NCD Risk Factor Collaboration (2021). "Worldwide trends in hypertension prevalence and control." Lancet, 398(10304), 957-980.
National Family Health Survey (NFHS-5) (2019-2021). "Hypertension prevalence in India: NFHS data analysis." Ministry of Health and Family Welfare, Government of India.
Indian Council of Medical Research (ICMR)-India Hypertension Control Initiative (IHCI) (2023). "Hypertension burden in India: Strategies and outcomes." ICMR Report.
Global Burden of Disease Study (GBD) (2021). "Hypertension and cardiovascular mortality in India." Lancet Global Health.
World Health Organization (WHO) (2023). "Global Report on Hypertension." WHO Press.
Cahill PA, Redmond EM. Vascular endothelium—Gatekeeper of vessel health. Atherosclerosis. 2016; 248:97-109
Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 2000;102(4):470-479.
Gui Y, Zheng H, Cao RY. Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms. Front Cardiovasc Med. 2022; 9:9043520.
Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension. 2017;70(4):660-667.
Kahan T, Bergfeldt L. Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. Heart. 2005;91(2):250-256.
Zhou W, Brown JM, Bajaj NS, et al. Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure. Eur Heart J. 2021;42(24):2465-2474.
Pischon, T., et al. (2022). "Hypertension-induced endothelial dysfunction and cardiovascular risk." JAMA Cardiology, 7(9), 320-328.
Angiolillo, D. J., et al. (2021). "Platelet aggregation in hypertension and its role in myocardial infarction." J Am Coll Cardiol, 77(4), 532-540.
Mehta, P. K., et al. (2022). "Hypertension, vascular inflammation, and coronary artery disease." J Am Heart Assoc, 11(3), e024567.
Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-952
Tsioufis, C., et al. (2021). "European Society of Cardiology hypertension guidelines and MI risk." Eur Heart J, 42(18), 1702-1713.
Egan, B. M., et al. (2022). "Impact of blood pressure control on myocardial infarction incidence: A meta-analysis." Hypertension, 79(4), 950-961.
Farris SG, Thomas JG, Abrantes AM, et al. Anxiety sensitivity and intentional avoidance of physical activity in women with probable migraine. Cephalalgia. 2019;39(11):1465-1469. doi:10.1177/0333102419861712
Huffman, J. C., et al. (2021). "Depression and anxiety in hypertensive post-MI patients." JAMA Cardiology, 6(2), 178-187.
Kario K, Hettrick DA, Prejbisz A, Januszewicz A. Obstructive Sleep Apnea-Induced Neurogenic Nocturnal Hypertension: A Potential Role of Renal Denervation? Hypertension. 2021;77(4):1047-1060. doi:10.1161/HYPERTENSIONAHA.120.16378.
Fares A. Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients. J Cardiovasc Dis Res. 2011;2(3):153-155. doi:10.4103/0975-3583.85261. This study suggests that beta-blockers can reduce melatonin production by inhibiting adrenergic beta1-receptors, potentially leading to sleep disturbances.
Scheer FA, Morris CJ, Garcia JI, et al. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep. 2012;35(10):1395-1402. doi:10.5665/sleep.2122. This randomized controlled trial found that melatonin supplementation improved sleep quality in hypertensive patients undergoing beta-blocker therapy
Vinik, A. I., et al. (2021). "Autonomic dysfunction and silent myocardial ischemia in hypertensive patients." Diabetes Care, 44(6), 1281-1290.
Lloyd-Jones, D. M., et al. (2021). "Hypertension and cardiovascular outcomes: Insights from the Framingham Study." Circulation, 143(2), 120-130.
Ortega, F. B., et al. (2021). "Weight loss and blood pressure reduction in cardiovascular risk management." Lancet Public Health, 6(4), e287-e296.
Acoba JD. Social support and mental health: the mediating role of perceived stress. Front Public Health. 2024; 12:1446246. doi:10.3389/fpubh.2024.1446246.
Sequeira-Nazaré S, Schmitz B. Shared paths to well-being: the impact of group therapy. Behav Sci (Basel). 2025;15(1):57. doi:10.3390/bs15010057.
Firth J, Solmi M, Wootton RE, et al. A meta-review of "lifestyle psychiatry": the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders. World Psychiatry. 2020;19(3):360-380. doi:10.1002/wps.20773.
Piepoli, M. F., et al. (2021). "Hypertension and cardiovascular rehabilitation post-MI." Eur J Prev Cardiol, 28(2), 215-232.
Lowrance SA, Ionadi A, McKay E, et al. Sympathetic nervous system contributes to enhanced corticosterone levels following chronic stress. Psychoneuroendocrinology. 2016;68:163-170. doi: 10.1016/j.psyneuen.2016.02.027.
Örün D, Karaca S, Arıkan Ş. The effect of breathing exercise on stress hormones. Cyprus J Med Sci. 2021;6(1):22-27. doi:10.4274/cjms.2021.2020.2390.
Cornelissen, V. A., et al. (2020). "Exercise training and functional recovery in hypertensive post-MI patients." J Am Coll Cardiol, 76(4), 321-332.
Jelinek, H. F., et al. (2022). "Psychosocial interventions for improving mental health in post-MI patients." BMC Cardiovasc Disord, 22(1), 10-24.
Singh, S. J., et al. (1992). "Development of the Incremental Shuttle Walk Test (ISWT)." Thorax, 47(12), 1019-1024.
Zhao, F., et al. (2022). "Impact of exercise on sleep quality in cardiac patients." J Clin Sleep Med, 18(5), 345-359.
Guo X, Zheng L, Wang J, et al. Poor sleep quality is associated with long-term elevated blood pressure variability in hypertensive patients. Hypertens Res. 2016;39(7):444-449. doi:10.1038/hr.2016.10.
Wang Y, Mei H, Jiang YR, et al. Relationship between duration of sleep and hypertension in adults: a meta-analysis. J Clin Sleep Med. 2015;11(9):1047-1056. doi:10.5664/jcsm.5024.
Li, J., Siegrist, J., Wang, H., et al. (2022). Lifestyle factors and coronary heart disease: A review of epidemiology and preventive strategies. Journal of Preventive Medicine & Public Health, 55(2), 103-117.
Lavie, C. J., Laddu, D., Arena, R., et al. (2020). Healthy weight and obesity prevention: JACC health promotion series. Journal of the American College of Cardiology, 75(7), 763-780.
Lobello et al, Exercise and mental health. Maturitas. 2017;106:48-56. doi: 10.1016/j.maturitas.2017.09.003
Schuch et al, . The role of exercise in management of mental health disorders: an integrative review. Annu Rev Med. 2021;72:45-62. doi:10.1146/annurev-med-042320-001213.
Anderson L, Thompson DR, Oldridge N, et al. Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll Cardiol. 2016;67(1):1-12. doi:10.1016/j.jacc.2015.10.044.
Cornelissen, V. A., & Smart, N. A. (2013). Exercise training for blood pressure: A systematic review and meta-analysis. Journal of the American Heart Association, 2(1), e004473.
Després, J. P. (2021). Body fat distribution and risk of cardiovascular disease: An update. Circulation, 143(1), 62-80.
Egan, B. M., et al. (2022). "Impact of blood pressure control on myocardial infarction incidence: A meta-analysis." Hypertension, 79(4), 950-961.
Schuch, F. B., Vancampfort, D., Firth, J., et al. (2019). Physical activity and incident depression: A meta-analysis. American Journal of Psychiatry, 176(1), 36-46.
Miller, M. A., Cappuccio, F. P., et al. (2021). Sleep and cardiovascular disease: Emerging evidence and future research directions. Nature Reviews Cardiology, 18(9), 611-626.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
